Anders J.
- Country
- Denmark
- Department
- Department of growth and reproduction
Research Overview
- Evaluation of Tildacerfont in Reducing Supraphysiologic Glucocorticoid Use in Adults with Classic Congenital Adrenal Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Tildacerfont and Hydrocortisone in Adults with Classic Congenital Adrenal Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 18 of 29 partner sites.
Specializations
Endocrine Disorders
The investigator specializes in the treatment of Classic Congenital Adrenal Hyperplasia (CAH), focusing on innovative therapeutic approaches for managing this genetic endocrine condition.
- Hormone Level Management
- Adrenal Function Regulation
- Endocrine System Disorders
Their research explores therapeutic interventions for addressing hormonal imbalances in CAH patients.
Therapeutic Development
The investigator conducts research into novel treatments for endocrine disorders, with particular attention to hormone regulation and metabolic control.
- Hormone Level Optimization
- Treatment Duration Assessment
- Long-term Therapeutic Outcomes
Their work includes evaluation of extended treatment periods to establish optimal therapeutic approaches.
Treatment Optimization
The investigator focuses on improving treatment protocols for patients with endocrine conditions, particularly in optimizing medication regimens.
- Medication Management
- Treatment Response Assessment
- Clinical Outcomes Evaluation
Their research aims to enhance therapeutic strategies for managing complex endocrine disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.